Screening of lipids and kidney function in children and adolescents with Type 1 Diabetes: does age matter?
age
guidelines
kidney function
lipids profile
type 1 diabetes
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
03
2023
accepted:
23
05
2023
medline:
20
6
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
epublish
Résumé
The purpose of this study was to evaluate lipid profile and kidney function in children and adolescents with Type 1 Diabetes. This was a retrospective study including 324 children and adolescents with Type 1 Diabetes (48% females, mean age 13.1 ± 3.2 years). For all participants, demographic and clinical information were collected. The prevalence of dyslipidemia and kidney function markers were analyzed according to age. Multivariate linear regression analyses were performed to test the association of lipids or markers of renal function with demographic and clinical information (sex, age, disease duration, BMI SDS, HbA1c). In our study the rate of dyslipidemia reached 32% in children <11 years and 18.5% in those ≥11 years. Children <11 years presented significantly higher triglyceride values. While the albumin-to-creatinine ratio was normal in all individuals, 17% had mildly reduced estimated glomerular filtration rate. Median of HbA1c was the most important determinant of lipids and kidney function, being associated with Total Cholesterol (p-value<0.001); LDL Cholesterol (p-value=0.009), HDL Cholesterol (p-value=0.045) and eGFR (p-value=0.001). Dyslipidemia could be present both in children and adolescents, suggesting that screening for markers of diabetic complications should be performed regardless of age, pubertal stage, or disease duration, to optimize glycemia and medical nutrition therapy and/or to start a specific medical treatment.
Identifiants
pubmed: 37334303
doi: 10.3389/fendo.2023.1186913
pmc: PMC10272791
doi:
Substances chimiques
Glycated Hemoglobin
0
Cholesterol, HDL
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1186913Informations de copyright
Copyright © 2023 Catamo, Robino, Dovc, Tinti, Tamaro, Bonfanti, Franceschi, Rabbone, Battelino and Tornese.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Diabetes Care. 2016 May;39(5):686-93
pubmed: 26861924
BMJ Open Diabetes Res Care. 2021 May;9(1):
pubmed: 34059526
Diabetes Care. 2023 Jan 1;46(Suppl 1):S230-S253
pubmed: 36507640
Diabetes Care. 2007 Sep;30(9):2187-92
pubmed: 17563337
J Diabetes Res. 2016;2016:2583747
pubmed: 26839891
Acta Diabetol. 2015 Feb;52(1):31-8
pubmed: 24849006
Diabetes. 2009 Jul;58(7):1651-8
pubmed: 19401416
Pediatr Diabetes. 2020 Dec;21(8):1546-1555
pubmed: 32939906
Diabet Med. 1998 Dec;15(12):1010-4
pubmed: 9868973
Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):2033-2041
pubmed: 34083127
J Am Soc Nephrol. 2009 Mar;20(3):629-37
pubmed: 19158356
J Pediatr. 1994 Aug;125(2):177-88
pubmed: 8040759
N Engl J Med. 1994 Jan 6;330(1):15-8
pubmed: 8259139
J Pediatr. 2013 Jan;162(1):101-7.e1
pubmed: 22795314
Diabetes Care. 2011 Nov;34(11):2368-73
pubmed: 22025782
Can J Diabetes. 2022 Jul;46(5):457-463.e1
pubmed: 35752567
Pediatr Diabetes. 2022 Dec;23(8):1432-1450
pubmed: 36537531
Eur Heart J. 2019 Nov 14;40(43):3559-3566
pubmed: 30863865
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
Pediatr Diabetes. 2007 Aug;8(4):193-8
pubmed: 17659060
Diabetes Care. 2006 Feb;29(2):218-25
pubmed: 16443863
Kidney Int. 2020 Jun;97(6):1117-1129
pubmed: 32409237
Cardiovasc Endocrinol Metab. 2019 Feb 13;8(1):28-34
pubmed: 31646295